title: Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura.
abstract: Thrombotic thrombocytopenia with severe depletion of plasma von Willebrand factor (vWF) was induced in normal large animals (5 dogs and 2 pigs) by botrocetin, a Bothrops factor requiring vWF for platelet agglutination. Botrocetin (90 to 100 U/kg, 2.14 to 2.38 mg/kg, in a single i.v. injection) reduced plasma vWF activity to < 0.1 U/mL for 24 hours. During this period, multimeric analysis of plasma vWF antigen (Ag) revealed the loss of intermediate- and high-molecular-weight forms with a concomitant increase in lower molecular weight forms. A moderate reduction in factor VIII (FVIII) activity was observed. The vWF reduction was accompanied by transient thrombocytopenia and prolonged bleeding times during the deficiency state. Occlusive platelet thrombi were detected by transmission electron microscopy in the microcirculation of lung and spleen but not kidney or brain 30 minutes after the botrocetin injection. Recovery of plasma vWF and platelet count occurred within 48 hours and was associated with the appearance in the plasma of unusually large forms of vWF:Ag multimers. The vWF:Ag multimer distribution was normal at 72 hours. The ultrastructural distribution of vWF in unstimulated normal porcine and canine platelets was examined by using immunogold staining. VWF was detected in the alpha-granules of normal pig platelets but was not observed in platelets from normal dogs. However, both animals developed thrombotic thrombocytopenia when injected with botrocetin. A second group of animals (2 dogs and 3 pigs) with von Willebrand disease (vWD) was given a single botrocetin injection (90 to 100 U/kg). No thrombocytopenia occurred.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Pathology, School of Medicine, University of North Carolina, Chapel Hill, USA.
authors.forename: W E
authors.initials: WE
authors.lastname: Sanders
authors.forename: R L
authors.initials: RL
authors.lastname: Reddick
authors.forename: T C
authors.initials: TC
authors.lastname: Nichols
authors.forename: K M
authors.initials: KM
authors.lastname: Brinkhous
authors.forename: M S
authors.initials: MS
authors.lastname: Read
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000378:metabolism* / Q000648:ultrastructure; D003435:Crotalid Venoms; D003594:Cytoplasmic Granules / Q000378:metabolism; D004195:Disease Models, Animal; D004285:Dogs; D005169:Factor VIII / Q000378:metabolism; D005260:Female; D007700:Kinetics; D046911:Macromolecular Substances; D008297:Male; D008854:Microscopy, Electron; D016253:Microscopy, Immunoelectron; D008970:Molecular Weight; D010974:Platelet Aggregation; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood* / Q000139:chemically induced / Q000473:pathology; D013552:Swine; D014842:von Willebrand Diseases; D014841:von Willebrand Factor / Q000032:analysis / Q000737:chemistry / Q000502:physiology*
chemical_list: D003435:Crotalid Venoms; D046911:Macromolecular Substances; D014841:von Willebrand Factor; C030961:botrocetin; D005169:Factor VIII